Guest View
User: Pass: | become a member
Posts Tagged ‘AMAG’

Options Active In Biotechnology Space

www.interactivebrokers.com

 

Today’s tickers: IBB, AMAG & AONE

IBB - iShares Nasdaq Biotechnology Index Fund – Shares in the IBB, an ETF that tracks the performance of the NASDAQ Biotechnology Index, an index containing securities of companies classified as either biotechnology or pharmaceuticals, are outperforming the S&P 500 this morning, up 0.40% at $112.73 as of 11:30 a.m. in New York. The Fund’s shares are slightly off their all-time high of $114.87 set last Thursday, and options activity on the ETF today suggests one strategist may be locking in recent gains ahead of a spate of earnings releases from companies in the Index. The top 10 holdings represent more than 50% of the total Index. Amgen, Inc. and Celgene Corp. are the two largest holdings, comprising approximately 8.8% and 6.6%, respectively. Both companies are scheduled to report earnings this Thursday. The strategist responsible for the single largest transaction in IBB options today may be hedging a long position in the index or components, or may be taking an outright bearish stance on the biotech and pharmaceuticals space during earnings season. The trader appears to have sold around 4,500 calls at the Mar. $115 strike in order to partially finance the purchase of a 4,500-lot Mar. $107/$112 put spread, all for a net premium outlay of $0.05 per contract. The sale of the call options greatly reduced the cost of the put spread, which may yield profits – or downside protection – to the investor in the event that shares in the IBB dip 0.70% to breach the effective breakeven price of $111.95. Maximum potential profits of $4.95 per contract are available on the position should shares drop 5.1% to settle at or below $107.00 at expiration. The short calls, if uncovered, could result in losses on the trade in the event that the Fund’s shares rally to new record highs by expiration in March.…
continue reading


Tags: , ,




Halliburton Options Trade Smartly

www.interactivebrokers.com

 Today’s tickers: HAL, CSTR, AMAG & FXI, SPY

HAL - Halliburton Co. – A sharp fall in Thursday’s session for oil services and sloppy cement-mixer Halliburton has not gained much traction at the end of the week. The stock today trades on both sides of unchanged and is currently at $31.71. While the prospects for additional liability are pretty much set out on the table following a report showing it provided BP with an unstable cement mix to surround the Macondo oil well, BP didn’t notice or attempt to rectify the error. Halliburton’s November puts are being sold as the stock stabilizes while the smart trade appears to be selling well out of the money call options expiring in April. Around 4,000 call options at the $36 strike price have traded to the bid telling us that an investor is taking a long stock and short call position or is simply just writing premium. The 52-week high at $35.89 remains a tall order after yesterday’s news making the short position in the calls look like a viable proposition.

CSTR - Coinstar Inc. – Coin and DVD-rental-machine operator Coinstar provided a pop for its shares after reporting surging revenues thanks to growth in its DVD-machine operations located in supermarket chains around the nation. Investors were primed for a dip in profits but were left smiling by a 42% increase in revenues on the movie-rental side. Call options on the stock were equally hot property on Friday after the share price jumped by 23% to $56.86. Formerly out-of-the-money call options expiring in November and which were trading at $1.50 yesterday traded all the way up to $8.00 a piece today despite a 20% slide in options implied volatility, typical after earnings. The share price surge put calls at six option strikes in-to-the-money on Friday. Compared to a 10-day average today’s overall options volume stacks up to more than five-times the norm.…
continue reading


Tags: , , , ,




Bears at Work as AMAG Pharmaceuticals Shares Head Lower

www.interactivebrokers.com

Today’s tickers: AMAG, BID, ERIC, BAX, NVDA, VIT, BVF & ETFC

AMAG – AMAG Pharmaceuticals, Inc. – Safety concerns surrounding AMAG’s Feraheme, the biopharmaceutical firm’s intravenous iron-replacement therapy for patients with chronic kidney disease and its lead product, continue to drive shares to new lows. Shares are down 4.00% at $18.15 as of 3:20 pm ET, but earlier plunged 11.6% to touch down at an intraday- and 4-year low of $16.70. Today’s low of $16.70 put shares down 68.2% since January 12, 2010, when the stock was trading up at its 52-week high of $52.49. Erosion in the price of AMAG’s shares accelerated at the end of August when the FDA added Feraheme to a list of products touting serious risks and connected the drug to unspecified serious cardiac disorders. One options investor appears to be positioning for shares to continue to decline by enacting a ratio put spread in the October contract. The trader purchased approximately 2,500 puts at the October $18 strike for premium of $1.98 each, and sold roughly 5,000 puts at the lower October $16 strike at a premium of $0.84 apiece. Average net premium paid to establish the spread amounts to $0.30 per contract. Thus, the strategist stands ready to profit if AMAG’s shares slip beneath the effective breakeven price of $17.70 by expiration. Maximum potential profits of $1.70 per contract are available to the trader if AMAG shares fall 11.85% from the current price of $18.15 to settle at $16.00 at expiration. The ratio of twice as much sold puts as long puts held by the investor expose him to losses should shares collapse below the effective lower breakeven price of $14.30 by expiration day next month.

BID – Sotheby’s, Inc. – Shares of the auctioneer fine art, antiques and other collectibles rallied as much as 7.65% this afternoon to touch an intraday high of $35.86. One options investor bought call options back in August and was well positioned to book profits on today’s rally. It looks like the trader originally purchased some 1,000 calls at the October $35 strike at an average premium of $0.90 each back on August 11, 2010, when BID’s shares were trading at a volume-weighted average price of $29.41. Shares have since increased significantly, boosting premium on the October $35 strike calls. Thus, the bullish player was able to sell all 1,000 lots at that strike for a premium…
continue reading


Tags: , , , , , , ,




DARK HORSE HEDGE

DARK HORSE HEDGE

By Scott at Sabrient and Ilene at Phil’s Stock World

Cover short AMAG at the Market, Thursday 7/29/10

Short RAIL at the Market, Thursday 7/29/10

AMAG lived up to expectations last night with a resounding -$1.01 versus expectations of -$.96 and revenues fell slightly short at a not-so-healthy $16 million from its main product, Feraheme.  Analyst Robert W. Baird immediately dropped AMAG from outperform to neutral and the stock has fallen -13.51%.  DHH added AMAG as a short on July 1, 2010 in anticipation of the “earnings” shortfall.  We believe it is best to “sell on the news” so we are recommending covering AMAG at the market. 

DHH will replace the short position in the virtual portfolio to maintain our BALANCED Long/Short tilt as the market is between the 50 and 200 day MA at this time. 

AMAG

Chart from FreeStockCharts.com (click on images or links if you can’t see the chart)

See also: AMAG slides on earnings report, downgrade, MW

SHORT FreightCar America (RAIL) at the market, July 29, 2010 

Continuing on DHH theme of looking for SHORT opportunities that continually disappoint on “earnings” day, we are adding RAIL to replace AMAG at the market.  RAIL is set to announce “earnings” on August 5, 2010 at 11am ET.  The eight analysts who follow RAIL expect a loss of -$.17 with a range of -$.24 on the low side to -$.10 on the high side.  Going back to Sept 2009, RAIL has disappointed analysts in a consistent fashion by delivering a profit of +$.09 versus expectations of +$.22 in September 2009, a loss of -$.47 in December 2009 when analysts were looking for a +$.04 gain, and again last quarter, when RAIL delivered -$.28 in the face of analysts’ projections of -$.17. 

RAIL is rated a STRONGSELL by Sabrient with a VALUE score of 25 (out of a possible 100) and a GROWTH score of 30 (out of 100).  DHH is in a BALANCED L/S tilt with 8 LONG and with the addition of RAIL 8 SHORT.  We will continue to monitor market trends to evaluate the need to change the tilt.

Chart from FreeStockCharts.com


Tags: , ,




DARK HORSE HEDGE – Covering AMAG, Shorting RAIL

DARK HORSE HEDGE 

By Scott at Sabrient and Ilene at Phil’s Stock World

Cover short AMAG at the Market, Thursday 7/29/10

Short RAIL at the Market, Thursday 7/29/10

AMAG lived up to expectations last night with a resounding -$1.01 versus expectations of -$.96 and revenues fell slightly short at a not-so-healthy $16 million from its main product, Feraheme.  Analyst Robert W. Baird immediately dropped AMAG from outperform to neutral and the stock has fallen -13.51%.  DHH added AMAG as a short on July 1, 2010 in anticipation of the “earnings” shortfall.  We believe it is best to “sell on the news” so we are recommending covering AMAG at the market. 

DHH will replace the short position in the virtual portfolio to maintain our BALANCED Long/Short tilt as the market is between the 50 and 200 day MA at this time. 

AMAG

Chart from FreeStockCharts.com (click on images or links if you can’t see the chart)

See also: AMAG slides on earnings report, downgrade, MW

SHORT FreightCar America (RAIL) at the market, 7/29/10 

Continuing on DHH theme of looking for SHORT opportunities that continually disappoint on “earnings” day, we are adding RAIL to replace AMAG at the market.  RAIL is set to announce “earnings” on August 5, 2010 at 11am ET.  The eight analysts who follow RAIL expect a loss of -$.17 with a range of -$.24 on the low side to -$.10 on the high side.  Going back to Sept 2009, RAIL has disappointed analysts in a consistent fashion by delivering a profit of +$.09 versus expectations of +$.22 in September 2009, a loss of -$.47 in December 2009 when analysts were looking for a +$.04 gain, and last quarter, when RAIL delivered -$.28 in the face of analysts’ projections of -$.17. 

RAIL is rated a STRONGSELL by Sabrient with a VALUE score of 25 (out of a possible 100) and a GROWTH score of 30 (out of 100).  DHH is in a BALANCED L/S tilt with 8 LONG and with the addition of RAIL 8 SHORT.  We will continue to monitor market trends to evaluate the need to change the tilt.

Chart from FreeStockCharts.com


Tags: , ,




DARK HORSE HEDGE UPDATE

DARK HORSE HEDGE UPDATE 

By Scott at Sabrient and Ilene of PSW

Black and white tilted view of horse grazing in meadow with wooden fence in foreground

You can run, you can run, tell my friend-boy, Willie Brown.
You can run, tell my friend-boy, Willie Brown.
Lord, that I’m standin’ at the crossroad, babe, I believe I’m sinking down.

Crossroads, Robert Johnson

Heading into Friday July 23, 2010 the market is again at a technical crossroad with the SPX closing Thursday at 1093.7, above the 50-day Moving Average of 1085.5. The MACD 12-26-9 remains close but still under the (zero) signal line at -1.13, with the RSI 14-day at 45.26.  There is lateral resistance at the 1096 level from the close last Thursday showing how the market has traveled a long way the past week to get nowhere.

Amazon.com Inc. (AMZN) fell short of analysts’ forecasts after Thursday’s close and was down 14% in after-hours trading, suggesting that the market may follow the pattern it has been in most of the summer.

Up 200, down 200, up 200, down 200 - wash out your savings, rinse and repeat!  What a total sham of a market we have these days with machines running us up and down on virtually no news at all.  Yesterday they would have you believe that Ben Bernanke caused a sell-off. How ridiculous is that?  He didn’t say one thing that he didn’t already say in the Fed Minutes that were released on the 14th, which were the notes from the meeting of June 23rd so for analysts to get on TV and say “the markets were concerned by the Chairman’s comments” is beyond stupid – it’s criminal negligence.  Phil’s Thrill-Ride Thursday.


[chart from freestockchart.com]

Thursday’s economic releases were less than encouraging with a jump in the number of people seeking unemployment benefits. Sales of previously owned homes fell, but the market shrugged it off as seasonal and rallied on the earnings of Caterpillar Inc., UPS Inc., and others that beat estimates. However, the…
continue reading


Tags: , , , , , , , , , , , ,




DARK HORSE HEDGE UPDATE

DARK HORSE HEDGE UPDATE 

Black and white tilted view of horse grazing in meadow with wooden fence in foreground

By Scott at Sabrient and Ilene of PSW

You can run, you can run, tell my friend-boy, Willie Brown.
You can run, tell my friend-boy, Willie Brown.
Lord, that I’m standin’ at the crossroad, babe,
I believe I’m sinking down.

- Crossroads, Robert Johnson

Heading into Friday July 23, 2010 the market is again at a technical crossroad with the SPX closing Thursday at 1093.7, above the 50-day Moving Average of 1085.5. The MACD 12-26-9 remains close but still under the (zero) signal line at -1.13, with the RSI 14-day at 45.26.  There is lateral resistance at the 1096 level from the close last Thursday showing how the market has traveled a long way the past week to get nowhere.

Amazon.com Inc. (AMZN) fell short of analysts’ forecasts after Thursday’s close and was down 14% in after-hours trading, suggesting that the market may follow the pattern it has been in most of the summer.

Up 200, down 200, up 200, down 200 - wash out your savings, rinse and repeat!  What a total sham of a market we have these days with machines running us up and down on virtually no news at all.  Yesterday they would have you believe that Ben Bernanke caused a sell-off. How ridiculous is that?  He didn’t say one thing that he didn’t already say in the Fed Minutes that were released on the 14th, which were the notes from the meeting of June 23rd so for analysts to get on TV and say “the markets were concerned by the Chairman’s comments” is beyond stupid – it’s criminal negligence.  Phil’s Thrill-Ride Thursday.


[chart from freestockchart.com]

Thursday’s economic releases were less than encouraging with a jump in the number of people seeking unemployment benefits. Sales of previously owned homes fell, but the market shrugged it off as seasonal and rallied on the earnings of Caterpillar Inc., UPS Inc., and others that beat estimates. However, the SPX hasn’t been able to break through resistance at 1096 and essentially has gone nowhere since last Thursday.…
continue reading


Tags: , , , , , , , , , , , , , , ,




DARK HORSE HEDGE

DARK HORSE HEDGE 7-18-10

By Scott at Sabrient and Ilene of PSW

Friday gave us a real-time example of why we use Hysteresis* and confirmations from our technical signals, MACD 12-26-9 and RSI 14-day, to select and monitor the tilt (long-short ratio) of the Dark Horse Hedge’s portfolio.  

The SHORT tilt Friday allowed us to make +1.37% from our 6 SHORT, 3 LONG positions while the S&P 500 gave back -2.88%.  The economic data out Friday of course played a large roll in the failure of our indicators to turn from short to BALANCED.  A sharp decline in the University of Michigan Consumer Index to 65 in July compared poorly with a June figure of 76 and Briefing.com’s estimate of 74.5.  Google’s earnings miss didn’t help either as the S&P 500 fell through its short-term support area to close at 1064.88.  The MACD reading is currently at -3.56 and RSI 14-day at 42.85 (bullish signal is above 50).  The preponderance of evidence heading into the July 19 week is that the market needs to find support in the 1040 range.  

Despite the poor economic data that pushed the market lower on Friday, 19 of 23 S&P 500 companies reporting thus far reported better than projected EPS, and 15 of them beat revenues as well.

Earnings reports will continue to flow in this week.  In our portfolio Western Digital Corp (WDC, long position) reports profits on Tuesday while USG Corp (USG, short position) and Sun Trust Banks Inc (STI, short position) report their losses on July 22.  We will continue to monitor the market action and look for guidance on entering new positions. Key support areas appear to be 1040, 1022 and then 995.

Dark Horse Hedge maintains 10% cash for swing trade opportunities and we are highlighting one for entry on Monday at the Open.

SHORT Terex Corp. (TEX) at the Open Monday.  

TEX will report its latest loss figures on Tuesday, July 21. Twenty analysts project losses ranging from -$.15 to -$.44 with an average of -$.30.  Looking back over the last four quarterly announcements, we see analysts often underestimate Terex’s losses.  For example, in March 2010, analysts estimated -$.52 while the actual loss was $.64. In December 2009, analysts targeted -$.49 and TEX delivered -$.89.  In September 2009, the loss was projected to be $.34 and the company came in at -$.77.  In June 2009, investors were…
continue reading


Tags: , , , , , , , , , , , , , , , , , ,




The Dark Horse Hedge

The Dark Horse Hedge

By Scott Brown at Sabrient, and Ilene, at Phil’s Stock World

Silhouette of Horses Jumping a Steeplchase

Scott Brown, Managing Director – Retail Division at Sabrient, is launching a newsletter with Phil’s Stock World based on the highly successful and popular Investors’ (H)Edge product.  The Dark Horse Hedge newsletter is a Long/Short retail portfolio taking advantage of technical market trends to tilt the balance of LONG vs. SHORT in bearish, bullish or range bound markets for added Alpha (the measure of return on a risk adjusted basis).  Long and short equity positions taken in The Dark Horse Hedge portfolio will be chosen using to Sabrient’s rating system, which is primarily based on fundamental criteria. Because the stock positions will generally be held for intermediate to long periods, these positions are ideal for using with option strategies taught by Phil Davis, of Phil’s Stock World.

The Dark Horse Hedge (DHH) newsletter will follow a number of guidelines in an attempt to minimize systemic risk, or “Beta.” Beta is a measure of the volatility of a portfolio in comparison to the market as a whole.  To keep beta low, the DHH portfolio will have both long and short positions.  Consequently, dramatic moves in the market will always be in the direction of at least part of the portfolio.

Using Sabrient’s rating system, we will focus on being long high quality stocks, and short low quality stocks.  Long positions should fare better than average during market selloffs.  In contrast, the short positions, selected from the lowest ranking stocks, should perform well during selloffs. These stocks are also expected to underperform higher quality names in a stronger market.  This strategy is designed to balance the goal of attaining Alpha with the desire to keep Beta relatively low.

We will follow this list of guidelines in building the DHH portfolio.

1.  When fully invested, the Portfolio will have 24 positions.  However the portfolio may not be fully invested.

2.  Tilting (or weighing) of the portfolio will be based on the position of the SPX relative to its 50 and 200 day Moving Averages

  • If the SPX is below both its 50


continue reading


Tags: , , , , , , , , , , ,




VIX-Investor Enacts Ratio Call Spread on Fear-Gauge

www.interactivebrokers.com

Today’s tickers: VIX, JPM, PEP, MDVN, TEX, EWZ, COST, RSH, AMAG & TIVO

VIX – CBOE Volatility index – The fear-gauge spent the better portion of the session in the red, but edged higher in late-afternoon trading to stand up 1.20% to 19.29. Options players busily populated the VIX with a number of interesting trades during the session. One transaction in particular, however, focused our attention on activity in the May contract. A hefty ratio call spread involving a total of 30,000 call options at deeply out-of-the-money strike prices was established on the VIX today. The investor purchased 10,000 calls at the May 27.5 strike for a premium of $1.50 apiece, and sold 20,000 calls at the higher May 35 strike for $0.70 each. The net cost of the transaction is reduced to just $0.10 per contract. It is possible the investor was motivated to put on the spread because of the low cost of the trade and because of the allure of potential profits going forward. The trader appears to believe the VIX will likely breach the breakeven point on the spread at 27.60 in the next three months to expiration, but doubts the fear-gauge will explode up to the mid-30’s. Evidence to support such a scenario is abundant. First, the investor can almost taste victory because the VIX traded as high as 29.22 on February 5, 2010, which is well above the point at which he garners profits. Second, losses above and beyond the premium paid to initiate the trade seem unlikely because the Index failed to rise above 30 since early November of last year. The resistance of the volatility index at the 30-level persisted despite the drop in global markets after China waved the fear-flag by announcing plans to rein in its country’s economic growth at the end of January. Additionally, angst regarding Europe’s debt crisis and threats to the strength of the Euro were also unable to boost the VIX up above 30. The ratio call spread described above looks to be a relatively cheap way to profit from another bout of market turmoil or jump in investor uncertainty ahead of May expiration. We note that the index must rally at least 43% from its current level before the investor breaks even on the transaction at 27.60.

JPM – JPMorgan Chase & Co. – The banking institution’s shares surrendered intraday gains of about 1% over…
continue reading


Tags: , , , , , , , , ,




 

Help One Of Our Own PSW Members

"Hello PSW Members –

This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible.  Feel free to contact me directly at jennifersurovy@yahoo.com with any questions.

Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts.  After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.)  Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.

http://www.youcaring.com/medical-fundraiser/help-get-shadowfax-out-from-the-darkness-of-medical-bills-/126743

Thank you for you time!

 
 

Zero Hedge

Goldman, Morgan Stanley Warn European QE, While Fully Priced In, Is Neither Imminent Nor Likely

Courtesy of ZeroHedge. View original post here.

Submitted by Tyler Durden.

On balance, Morgan Stanley feels that broad-based QE, (i.e. large-scale purchases of government bonds) is further away for the ECB than the market currently believes. Presently they only assign a subjective 40% probability to such a step being taken; whereas the euro rates market is already pricing in the ECB resorting to a broad-based purchase programme with a very high probability of 80-100%. Goldman agrees warning specifically that "Sovereign QE is not imminent... and indeed may never happen." It appears no matter what, disappointment is guaranteed for the market.

 

As Morgan Stanley ...



more from Tyler

Chart School

Moving Averages: Month-End Preview

Courtesy of Doug Short.

Here is a preview of the monthly moving averages I track after the close of the last business day of the month. All three S&P 500 strategies are now signaling "invested" -- unchanged from last month. Two of the five of the Ivy Portfolio ETFs, the PowerShares DB Commodity Index Tracking (DBC and the Vanguard FTSE All-World ex-US ETF (VEU), are signal cash "cash" -- also unchanged from last month.

If a position is less than 2% from a signal, it is highlighted in yellow.


Note: My inclusion of the S&P 500 index updates is intended to illustrate a popular moving moving-average timing strategy. The index signals also give a general sense of how US equities are behaving. Howe...



more from Chart School

Phil's Favorites

Why Mitochondria Matter

Patrick starts by reviewing what a "broken record" is. (Sadly, I know and you probably do too.) He notes that biotechnology has undergone more enormous changes than the music delivery industry, and that most people do not have a proper appreciation of how big this "biotech transformation" is. Then, he reviews what mitochondria are, how they work and why they are so important to us.

Within all the cells of our bodies, microchondria produce energy - the energy supply needed to run the cells' activities. Without the ability to take nutrients and convert them to energy, via these little cellular machines, we are dead. And that, in brief, is why mitochondria are important. 

Illustration of a Mitochondrion by Kelvinsong, modified by ...



more from Ilene

All About Trends

Mid-Day Update

Reminder: David is available to chat with Members, comments are found below each post.

Click here for the full report.




To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

more from David

Insider Scoop

Jennings Capital Downgrades Ballard Power Systems

Courtesy of Benzinga.

Related BLDP Lake View: Ballard Power Systems 'Making Progress' Morning Market Movers

Jennings Capital downgraded Ballard Power Systems Inc. (NASDAQ: BLDP) in a report issued Thursday from Buy to Hold and lowered its price target from $5 to $3.

Analyst Dev Bhangui noted that the company "reported Q3/14 results that were below our and consensus estimates. EPS were ($0.02) versus JCI and consensus of ($0.01). Revenue and gross margin m...



http://www.insidercow.com/ more from Insider

Sabrient

Sector Detector: Bullish conviction returns, but market likely to consolidate its V-bottom

Courtesy of Sabrient Systems and Gradient Analytics

Bulls showed renewed backbone last week and drew a line in the sand for the bears, buying with gusto into weakness as I suggested they would. After all, this was the buying opportunity they had been waiting for. As if on cue, the start of the World Series launched the rapid market reversal and recovery. However, there is little chance that the rally will go straight up. Volatility is back, and I would look for prices to consolidate at this level before making an attempt to go higher. I still question whether the S&P 500 will ultimately achieve a new high before year end.

In this weekly update, I give my view of the current market environment, offer a technical analysis of the S&P 500 chart, review our weekly fundamentals-based SectorCast rankings of the ten U.S. business sectors, and then o...



more from Sabrient

OpTrader

Swing trading portfolio - week of October 27th, 2014

Reminder: OpTrader is available to chat with Members, comments are found below each post.

 

This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...



more from OpTrader

Stock World Weekly

Stock World Weekly

Newsletter writers are available to chat with Members regarding topics presented in SWW, comments are found below each post.

Here's the latest Stock World Weekly. Enjoy!

(As usual, use your PSW user name and password to sign in. You may also take a free trial.) 

 

#455292918 / gettyimages.com

 

...

more from SWW

Market Shadows

Bill Ackman's Big Pharma Trade Is Making Wall Street A Super Awkward Place

 

#452525522 / gettyimages.com

Intro by Ilene

If you're following Valeant's proposed takeover (or merger) of Allergan and the lawsuit by Allergan against Valeant and notorious hedge fund manager William Ackman, for insider trading this is a must-read article. 

Linette Lopez describes the roles played by key Wall Street hedge fund owners--Jim Chanos, John Paulson, and Mason Morfit, a major shareholder in Valeant. Linette goes through the con...



more from Paul

Option Review

LUV Options Active Ahead Of Earnings

There is lots of action in Southwest Airlines Co. November expiry call options today ahead of the air carrier’s third-quarter earnings report prior to the opening bell on Thursday. Among the large block trades initiated throughout the trading session, there appears to be at least one options market participant establishing a call spread in far out of the money options. It looks like the trader purchased a 4,000-lot Nov 37/39 call spread at a net premium of $0.40 apiece. The trade makes money if shares in Southwest rally 9.0% over the current price of $34.32 to exceed the effective breakeven point at $37.40, with maximum potential profits of $1.60 per contract available in the event that shares jump more than 13% to $39.00 by expiration. In September, the stock tou...



more from Caitlin

Digital Currencies

Goodbye War On Drugs, Hello Libertarian Utopia. Dominic Frisby's Bitcoin: The Future of Money?

Courtesy of John Rubino.

Now that bitcoin has subsided from speculative bubble to functioning currency (see the price chart below), it’s safe for non-speculators to explore the whole “cryptocurrency” thing. So…is bitcoin or one of its growing list of competitors a useful addition to the average person’s array of bank accounts and credit cards — or is it a replacement for most of those things? And how does one make this transition?

With his usual excellent timing, London-based financial writer/actor/stand-up comic Dominic Frisby has just released Bitcoin: The Future of Money? in which he explains all this in terms most readers will have no tr...



more from Bitcoin

Pharmboy

Biotechs & Bubbles

Reminder: Pharmboy is available to chat with Members, comments are found below each post.

Well PSW Subscribers....I am still here, barely.  From my last post a few months ago to now, nothing has changed much, but there are a few bargins out there that as investors, should be put on the watch list (again) and if so desired....buy a small amount.

First, the media is on a tear against biotechs/pharma, ripping companies for their drug prices.  Gilead's HepC drug, Sovaldi, is priced at $84K for the 12-week treatment.  Pundits were screaming bloody murder that it was a total rip off, but when one investigates the other drugs out there, and the consequences of not taking Sovaldi vs. another drug combinations, then things become clearer.  For instance, Olysio (JNJ) is about $66,000 for a 12-week treatment, but is approved for fewer types of patients AND...



more from Pharmboy



FeedTheBull - Top Stock market and Finance Sites



About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>